| Structure |
Chemical Name |
CAS |
MF |
 |
ETHYL 5-ISOPROPYL-3-METHYLISOXAZOLE-4-CARBOXYLATE |
357326-79-5 |
C10H15NO3 |
 |
((2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methanol hydrochloride |
2416218-32-9 |
C8H14FNO.ClH |
![(S)-4-[1-hydroxy-2-(methylamino)ethyl]pyrocatechol](/CAS/GIF/150-05-0.gif) |
(S)-4-[1-hydroxy-2-(methylamino)ethyl]pyrocatechol |
150-05-0 |
C9H13NO3 |
 |
3-acetyl-4-hydroxy-2-benzopyrone |
2555-37-5 |
C11H8O4 |
![5-Pyrimidinecarboxylic acid, 2-[[4-[[2-(dimethylamino)ethyl]methylamino]-2-methoxy-5-nitrophenyl]amino]-4-(1-methyl-1H-indol-3-yl)-, 1-methylethyl ester](/CAS/20211123/GIF/1847464-89-4.gif) |
5-Pyrimidinecarboxylic acid, 2-[[4-[[2-(dimethylamino)ethyl]methylamino]-2-methoxy-5-nitrophenyl]amino]-4-(1-methyl-1H-indol-3-yl)-, 1-methylethyl ester |
1847464-89-4 |
C29H35N7O5 |
![Cyclopenta[d]-1,2,3-oxathiazole-3(3aH)-carboxylic acid, tetrahydro-, 1,1-dimethylethyl ester, 2,2-dioxide, (3aS,6aR)-](/CAS/20210305/GIF/2145122-45-6.gif) |
Cyclopenta[d]-1,2,3-oxathiazole-3(3aH)-carboxylic acid, tetrahydro-, 1,1-dimethylethyl ester, 2,2-dioxide, (3aS,6aR)- |
2145122-45-6 |
C10H17NO5S |
 |
4-MAR |
|
|
 |
27-Demethyl Rifampicin |
|
|
 |
Sunitinib Malate E-Isomer |
|
|
 |
Δ3-Ceftiofur |
|
|
 |
N-(4-CYANO-PHENYL)-GLYCINE |
42288-26-6 |
C9H8N2O2 |
 |
DeoxyBenzoinOxime |
952-06-7 |
C14H13NO |
![(2S,5R)-6-(tert-butyldimethylsilyloxy)-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-ene-2-carboxamide](/CAS/20210305/GIF/2209874-02-0.gif) |
(2S,5R)-6-(tert-butyldimethylsilyloxy)-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-ene-2-carboxamide |
2209874-02-0 |
C14H25N3O3Si |
 |
20-hydroxy Prostaglandin F2a |
|
|
![1,6-Diazabicyclo[3.2.1]oct-3-ene-2-carboxamide, 6-hydroxy-3-methyl-7-oxo-, (1R,2S,5R)-](/CAS/20210305/GIF/2209874-17-7.gif) |
1,6-Diazabicyclo[3.2.1]oct-3-ene-2-carboxamide, 6-hydroxy-3-methyl-7-oxo-, (1R,2S,5R)- |
2209874-17-7 |
C8H11N3O3 |
 |
Methyl 5-amino-2,4-difluorobenzoate |
125568-73-2 |
C8H7F2NO2 |
 |
3-Acetylbiphenyl |
3112-01-4 |
C14H12O |
 |
(S)-3-Cyano-5-methylhexanoic acid ethyl ester |
181289-39-4 |
C10H17NO2 |
 |
methyl 2-(4-(tert-butoxycarbonyl)piperazin-1-yl)pyrimidine-5-carboxylate |
1057682-17-3 |
C15H22N4O4 |
 |
tert-butyl (R)-2-(2,2-difluoroethyl)piperazine-1-carboxylate |
|
|
![[R-[R*,R*-(Z)]]-α-[[(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-1,2,5,7-tetrahydro-7-oxo-4H-Furo[3,4-d][1,3]thiazine-2-acetic Acid](/CAS/20210305/GIF/75679-12-8.gif) |
[R-[R*,R*-(Z)]]-α-[[(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-1,2,5,7-tetrahydro-7-oxo-4H-Furo[3,4-d][1,3]thiazine-2-acetic Acid |
75679-12-8 |
C14H15N5O6S2 |
 |
△3-Cefuroxime |
|
|
 |
Flomoxef Intermediate KDFA |
|
|
 |
Polymethylhydrosiloxane |
9004-73-3 |
C5H11OSi* |
 |
4S-fluoropyrrolidine-2R-carboxylic acid methyl ester hydrochloride salt |
131176-03-9 |
C6H11ClFNO2 |
 |
LOXO-292 |
2222755-14-6 |
C29H31N9O3 |
![1-Piperazinecarboxylic acid, 2-methyl-5-[[(3R)-3-methyl-4-morpholinyl]methyl]-, 1,1-dimethylethyl ester, (2R,5S)-](/CAS/20200331/GIF/1403902-78-2.gif) |
1-Piperazinecarboxylic acid, 2-methyl-5-[[(3R)-3-methyl-4-morpholinyl]methyl]-, 1,1-dimethylethyl ester, (2R,5S)- |
1403902-78-2 |
C16H31N3O3 |
 |
PROSTAGLANDIN J2 |
60203-57-8 |
C20H30O4 |
 |
Prednisone Impurity 13 |
91160-89-3 |
C23H29BrO7 |
 |
Thionicotinamide |
4621-66-3 |
C6H6N2S |
 |
1-(tert-butyl) 4-ethyl (3R,4R)-3-hydroxypiperidine-1,4-dicarboxylate |
206111-36-6 |
C13H23NO5 |
 |
7 8-DIHYDROXY-4-PHENYLCOUMARIN |
842-01-3 |
C15H10O4 |
 |
1,4-dihydroxy-2naphthoic acid methyl ester |
77060-74-3 |
C12H10O4 |
![(7R,13S,17S)-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)thio)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diyl diacetate](/CAS/20211123/GIF/1428484-17-6.gif) |
(7R,13S,17S)-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)thio)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diyl diacetate |
1428484-17-6 |
C36H51F5O4S |
 |
2’,3’-dideoxy-2’,3’-didehydroinosine |
|
|
 |
Fmoc-Ala-Ala-Asn-PABC-PNP |
1834516-06-1 |
C39H38N6O11 |
 |
2’-deoxyinosine |
|
|
 |
Anti-Ceftriaxong |
|
|
 |
benzyl (R)-2-(2,2-difluoroethyl)piperazine-1-carboxylate |
|
|
 |
tert-butyl (S)-2-((trifluoromethoxy)methyl)piperazine-1-carboxylate |
|
|
 |
tert-butyl (S)-2-(2,2,2-trifluoroethyl)piperazine-1-carboxylate |
1240582-25-5 |
C11H19F3N2O2 |
 |
4-hydroxy-6H-coumarin |
213481-01-7 |
C15H15NO3 |
 |
1-Azetidinecarboxylic acid, 3-(4-iodo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester |
951259-19-1 |
C11H16IN3O2 |
 |
Biapenem Impurity A Dimer |
|
|
 |
Cefuroxime Impurity 1(Cefuroxime Mother Nucleus) |
|
|
 |
2-(4-METHOXY-BENZYL)-2H-PYRAZOL-3-YLAMINE |
3528-45-8 |
C11H13N3O |
 |
Ozagrel sodium |
130952-46-4 |
C13H13N2NaO2 |
 |
5-Mercapto-1H-tetrazole-1-methane sulphonic acid |
67146-22-9 |
C2H4N4O3S2 |
 |
Trityl candesartan cilexetil |
170791-09-0 |
C52H48N6O6 |
 |
Chloropretadalafil |
171489-59-1 |
C22H19ClN2O5 |
![5.7-Dioxa-6-thia-spiro[2.5]octane-6-oxide](/CAS/GIF/89729-09-9.gif) |
5.7-Dioxa-6-thia-spiro[2.5]octane-6-oxide |
89729-09-9 |
C5H8O3S |
 |
8-Benzyloxy-2'-deoxy-D-guanosine |
96964-90-8 |
C17H19N5O5 |
 |
3-FLUOROINDOLE |
66946-81-4 |
C8H6FN |
 |
Cefetecol |
117211-03-7 |
C20H17N5O9S2 |
 |
Vorapaxar |
900161-12-8 |
C29H34N2O5 |
 |
tert-butyl 4,4-Dimethyl-2,2-dioxooxathiazolidine-3-carboxylate |
454248-55-6 |
C9H17NO5S |
 |
1-Boc-4-(4-fluoro-phenylamino)-piperidine |
288573-56-8 |
C16H23FN2O2 |
 |
(r)-tert-butyl 5-methyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide |
863453-61-6 |
C8H15NO5S |
 |
tert-butyl (2S)-2-(hydroxymethyl)-2-methylpyrrolidine-1-carboxylate |
1339022-10-4 |
C11H21NO3 |
 |
1-Pyrrolidinepropanol, β-amino-α-(2,3-dihydro-1,4-benzodioxin-6-yl)-, (αR,βR)- |
491833-28-4 |
C15H22N2O3 |
 |
tert-butyl 4-(3-(methoxycarbonyl)phenyl)piperidine-1-carboxylate |
1016980-41-8 |
C18H25NO4 |
![[3,3']Biazetidinyl-1-carboxylicacidtert-butylester](/CAS/20180527/GIF/1251018-87-7.gif) |
[3,3']Biazetidinyl-1-carboxylicacidtert-butylester |
1251018-87-7 |
C11H20N2O2 |
 |
4-(Bromomethyl)-7-(diethylamino)coumarin |
1256259-14-9 |
C14H16BrNO2 |
 |
TERT-BUTYL 3-((2-ETHOXY-2-OXOETHYL)SULFONYL)AZETIDINE-1-CARBOXYLATE |
1648864-57-6 |
C12H21NO6S |
 |
2-Oxo-1-benzimidazolinebutyric Acid |
3273-68-5 |
C11H12N2O3 |
 |
(1S,2R)-METHYL 2-(2-HYDROXYETHYL)CYCLOPROPANECARBOXYLATE |
2165933-01-5 |
C7H12O3 |
![methyl 3-{[(tert-butoxy)carbonyl]amino}-5-iodothiophene-2-carboxylate](/CAS/20200119/GIF/1007171-35-8.gif) |
methyl 3-{[(tert-butoxy)carbonyl]amino}-5-iodothiophene-2-carboxylate |
1007171-35-8 |
C11H14INO4S |
![ethyl 7-[6-[benzoyl(methyl)amino]-5-methyl-3-pyridyl]-1-cyclopropyl-8-methyl-4-oxo-quinoline-3-carboxylate](/CAS/20200119/GIF/446299-90-7.gif) |
ethyl 7-[6-[benzoyl(methyl)amino]-5-methyl-3-pyridyl]-1-cyclopropyl-8-methyl-4-oxo-quinoline-3-carboxylate |
446299-90-7 |
C30H29N3O4 |
 |
6,7-dichloro-4-methyl- 2H-chromen-2-one |
923019-32-3 |
C10H6Cl2O2 |
 |
3-(2-ETHOXYCARBONYL-ACETYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER |
877173-80-3 |
C15H25NO5 |
 |
(3R,5S,2S,3S)-posaconazole |
|
|
 |
Fmoc-Gly-Gly-Phe-OH |
160036-44-2 |
C28H27N3O6 |
 |
(R)-3-Aminopentanoic acid |
131347-76-7 |
C5H11NO2 |
 |
Tachysterol 3 |
17592-07-3 |
C27H44O |
 |
tert-butyl 4-bromo-3-(bromomethyl)thiophene-2-carboxylate |
|
|
 |
Zanamivir |
139110-70-6 |
C18H26N2O10 |
 |
1-Piperazinecarboxylic acid, 4-(1,3-dihydro-1-oxo-5-isobenzofuranyl)-, 1,1-dimethylethyl ester |
1962174-33-9 |
C17H22N2O4 |
 |
Prostaglandin E synthase 3 (PTGES3) Antibody |
|
|
![(S)-4-Ethyl-4-hydroxy-7,8-dihydro-1h-pyrano[3,4-f]indolizine-3,6,10(4h)-trione](/CAS/GIF/110351-94-5.gif) |
(S)-4-Ethyl-4-hydroxy-7,8-dihydro-1h-pyrano[3,4-f]indolizine-3,6,10(4h)-trione |
110351-94-5 |
C13H13NO5 |
 |
13,14-dihydro Prostaglandin F2a |
|
|
 |
Boldenone Cypionate |
106505-90-2 |
C27H38O3 |
 |
benzyl (2R,5R)-5-(hydroxymethyl)-2-methylpiperazine-1-carboxylate |
|
|
 |
Methanesulfonic anhydride |
370071-69-5 |
C8H6Br4O2 |
 |
Olmesartan intermediate |
|
|
 |
L-Inosine |
21138-24-9 |
C10H12N4O5 |
 |
1H-Pyrrolizine-7a(5H)-carboxylicacid,tetrahydro-,methylester(9CI) |
117375-15-2 |
C9H15NO2 |
 |
5-iodo-1-(2-fluoro-2-deoxyribofuranosyl)uracil |
55612-21-0 |
C9H10FIN2O5 |
![5-(Difluoromethoxy)-2[[(4-chloro-3-methoxy-2-pyridinyl)methyl]-thio]-1H-benzimidazole](/CAS/GIF/368890-20-4.gif) |
5-(Difluoromethoxy)-2[[(4-chloro-3-methoxy-2-pyridinyl)methyl]-thio]-1H-benzimidazole |
368890-20-4 |
C15H12ClF2N3O2S |
 |
Morpholin-2-yl-methylamine |
116143-27-2 |
C5H12N2O |
![3-AMINO-8-BENZYL-8-AZABICYCLO[3.2.1]OCTANE (3-EXO)-](/CAS/GIF/76272-36-1.gif) |
3-AMINO-8-BENZYL-8-AZABICYCLO[3.2.1]OCTANE (3-EXO)- |
76272-36-1 |
C14H20N2 |
![(1s-trans)-2-[(phenylmethoxy)methyl]-3-cyclopenten-1-ol](/CAS/GIF/188399-48-6.gif) |
(1s-trans)-2-[(phenylmethoxy)methyl]-3-cyclopenten-1-ol |
188399-48-6 |
C13H16O2 |
 |
7-Fluoroindole |
387-44-0 |
C8H6FN |
 |
DMT-2'O-TBDMS-rA(bz) Phosphoramidite |
104992-55-4 |
C53H66N7O8PSi |
 |
(S)-(2-Aminomethyl)-1-N-Boc-pyrrolidine HCl |
1190890-11-9 |
C10H21ClN2O2 |
 |
3',5'-di-o-acetyl-2-deoxy-5-azacytosine |
22432-93-5 |
C12H16N4O6 |
 |
(2S,4S)-1-(tert-Butoxycarbonyl)-4-fluoro-2-hydroxymethylpyrrolidine |
317356-27-7 |
C10H18FNO3 |
 |
(S)-2-(((3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-3-phenylpropanoic acid methyl ester hydrochloride |
170098-28-9 |
C24H31NO3.HCl |
![4a,5,9,10,11,12-hexahydro-1-bromo-3-methoxy-11-formyl-6H-benzofuro[3a,3,2-ef
][2]benzazepin-6-one](/CAS/GIF/122584-14-9.gif) |
4a,5,9,10,11,12-hexahydro-1-bromo-3-methoxy-11-formyl-6H-benzofuro[3a,3,2-ef
][2]benzazepin-6-one |
122584-14-9 |
C17H16BrNO4 |
 |
TF-BF |
209861-00-7 |
C24H22F2O5 |
 |
Cefaclor, Delta-3 IsoMer |
|
|